First-of-its-Kind immune cell therapy trial launches for Tough-to-Treat cancers
Disease control
Recruiting now
This is an early-stage trial testing a new, personalized immune cell therapy for people with metastatic colorectal or prostate cancer. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and give them back to the patient multiple times. …
Phase: PHASE1, PHASE2 • Sponsor: Curacell Holding AB • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC